{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P52948",
      "entity_text" : "ADAR2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00126",
      "entity_text" : "PKCzeta",
      "features" : [ {
        "modification_type" : "phosphorylation",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Consistent with PKCzeta phosphorylation mediating ADAR2 activity, we observed hypo editing of coatamer protein alpha (COPA), which has previously been reported to be a substrate of ADAR2 and to be hypo edited in cancer.",
  "reading_complete" : "2020-08-08T18:14:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:12:44Z",
  "trigger" : "mediating",
  "evidence" : [ "PKCzeta phosphorylation mediating ADAR2" ],
  "pmc_id" : "5958623",
  "score" : 0
}